GM-CSF in chemotherapy-induced febrile neutropenia - A double-blind randomized study

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1255-1260

  Arnberg, Henrik ^a   Letocha, Henry ^a   Nõu, Fnn ^a   Westlin, Jan Frik ^a   Nilsson, Sten ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemotherapy induced; Febrile neutropenia; Granulocyte macrophage colony stimulating factor (GM CSF); Placebo controlled study; Randomised

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BONE MARROW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; MALE; MYCOSIS; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; ESCHERICHIA COLI; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPENIA; PLACEBOS; TIME FACTORS;

EID: 0031857995     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Demetri GD, Antaman KHS: Glanulocyte-Macrophage Colony-Stimulating Factor (GM-CSF): preclinical and clinical observations. Sem in Oncol 19(4): 362-385, 1992.
2. Gerhartz HH, Stern AC, Wolf-Hornung B, Kazempour M, Schmezter H et al Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor in patients undergoing cancer chemotherapy. Leukemia Research 17: 175-185, 1993.
3. Gerhartz HH, Engelhard M, Brittinger G, Wilmanns W, Schlimok G et al: Prevention of chemotherapy-induced neutropenia by human recombinant granulocyte/macrophage colony-stimulating factor. Annals of Hematology 67, Suppl 2A: 144, 1993.
4. Sarinen UM, Hovi L, Riikonen P, Pihkala J, Juvonen E: Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy induced neutropenia. Med Ped Oncol 20: 489-496, 1992.
5. Cebon J, Layton JE, Maher D, Morstyn G: Endogenous hematopoietic growth factors in neutropenia and infection. Br J Haemat 86: 265-274, 1994.
6. Groopman JE, Molina JM, Scadden DT: Hematopoietic growth factors. N Engl J Med 321: 1449-1459, 1989.
7. Crosier PS, Clark SC: Basic biology of hematopoietic growth factors. Sem Oncol 19(4): 349-361, 1992.
8. Singer JW, Role of colony-stimulating factors in bone-marrow transplantation. Sem Oncol 19(3): 27-31, 1992.
9. Quesenberry PJ: Biomodulation of chemotherapy-induced myelosuppression. Sem Oncol 19(3): 8-13, 1992.
10. Wodzinski MA, Hampton KK, Reilly JT: Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia. Br J Haemat 77: 249-250, 1991.
11. Kaczmarski RS; Mufti GJ: rH GM-CSF in neutropenia secondary to myelodysplastic syndrome. Clin Sci 80, Suppl 24, abstract 123, 1991.
12. Groopman JE, Mitsuyasu RT DeLeo MJ Oette DH, Golde DW: Effect of rH GM-CSF on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317: 593-698, 1987.
13. Brown CC, Gallin JI: Chemotactic disorders. Hematology/Oncology Clinics of North America 2: 61-79, 1988.
14. Metcalf D. Hematopoietic growth factors: redundancy or subtlety? Blood 82:12, 3515-1523, 1993.
15. Petros WP, Peters WP: Hematopoietic colony-stimulating factors and dose intensity. Sem Oncol 20:1, 94-99, 1993.
16. Hansen PB, Johnsen HE, Ralfkiaer E, Hansen NE: Blood neutrophil increment after a single injection of rH G-CSF or rH GM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy. Br J Haemat 84: 581-585, 1993.